Kevin Hourican Sysco Corp (SYY) insider trading activity

SYY Quotes by TradingView

Kevin Hourican is Chair and CEO of SYSCO CORP. Currently has a direct ownership of 409,186 shares of SYY, which is worth approximately $31.5 Million. The most recent transaction as insider was on Sep 03, 2024, when has been sold 6,811 shares (Common Stock) at a price of $77.97 per share, resulting in proceeds of $531,053. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 409K
0% 3M change
20.18% 12M change
Total Value Held $31.5 Million

Kevin Hourican Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 03 2024
SELL
Payment of exercise price or tax liability
$531,053 $77.97 p/Share
6,811 Reduced 1.64%
409,186 Common Stock
Aug 21 2024
BUY
Grant, award, or other acquisition
-
49,420 Added 10.62%
415,997 Common Stock
Aug 12 2024
SELL
Payment of exercise price or tax liability
$477,149 $75.63 p/Share
6,309 Reduced 1.69%
366,577 Common Stock
Aug 01 2024
SELL
Payment of exercise price or tax liability
$1,607,074 $76.44 p/Share
21,024 Reduced 5.34%
372,886 Common Stock
Aug 01 2024
BUY
Grant, award, or other acquisition
$4,083,883 $76.44 p/Share
53,426 Added 11.94%
393,910 Common Stock
Sep 01 2023
SELL
Payment of exercise price or tax liability
$783,910 $69.65 p/Share
11,255 Reduced 3.2%
340,483 Common Stock
Aug 10 2023
BUY
Grant, award, or other acquisition
-
48,096 Added 12.03%
351,738 Common Stock
Oct 24 2022
SELL
Open market or private sale
$6,093,043 $81.22 p/Share
75,019 Reduced 19.81%
303,642 Common Stock
Oct 24 2022
BUY
Exercise of conversion of derivative security
$4,357,104 $58.08 p/Share
75,019 Added 16.54%
378,661 Common Stock
Sep 01 2022
SELL
Payment of exercise price or tax liability
$645,427 $82.22 p/Share
7,850 Reduced 2.52%
303,642 Common Stock
Aug 18 2022
BUY
Grant, award, or other acquisition
-
25,961 Added 7.69%
311,492 Common Stock
Jul 29 2022
SELL
Payment of exercise price or tax liability
$11,159,010 $87.28 p/Share
127,853 Reduced 30.93%
285,531 Common Stock
Jul 29 2022
BUY
Grant, award, or other acquisition
-
324,907 Added 47.45%
359,869 Common Stock
Apr 08 2022
SELL
Open market or private sale
$6,451,548 $86.0 p/Share
75,018 Reduced 45.88%
88,477 Common Stock
Apr 08 2022
BUY
Exercise of conversion of derivative security
$4,357,046 $58.08 p/Share
75,018 Added 31.45%
163,495 Common Stock
Sep 01 2021
SELL
Payment of exercise price or tax liability
$353,965 $79.65 p/Share
4,444 Reduced 4.78%
88,477 Common Stock
Aug 19 2021
BUY
Grant, award, or other acquisition
-
25,960 Added 21.84%
92,921 Common Stock
Aug 02 2021
SELL
Payment of exercise price or tax liability
$797,056 $74.2 p/Share
10,742 Reduced 13.82%
66,961 Common Stock
Feb 01 2021
SELL
Payment of exercise price or tax liability
$769,948 $71.51 p/Share
10,767 Reduced 12.17%
77,703 Common Stock

Also insider at

CVS
CVS HEALTH Corp Healthcare
EVP & President, CVS Pharmacy
TPR
TAPESTRY, INC. Consumer Cyclical
Director
KH

Kevin Hourican

Chair and CEO
Woonsocket, RI

Track Institutional and Insider Activities on SYY

Follow SYSCO CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SYY shares.

Notify only if

Insider Trading

Get notified when an Sysco Corp insider buys or sells SYY shares.

Notify only if

News

Receive news related to SYSCO CORP

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SYY